Last update 14 Oct 2025

NEU-5123

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NEU 5123
Target-
Action
inhibitors
Mechanism
kinase inhibitor
Therapeutic Areas
Infectious DiseasesSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
Leishmaniasis, CutaneousTrypanosomiasis, African
Inactive Indication-
Originator Organization
Northeastern UniversityNortheastern UniversityGSK PlcGSK Plc
Active Organization
GSK PlcGSK PlcNortheastern UniversityNortheastern University
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with NEU-5123
Login to view more data
100 Translational Medicine associated with NEU-5123
Login to view more data
100 Patents (Medical) associated with NEU-5123
Login to view more data
100 Deals associated with NEU-5123
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Leishmaniasis, CutaneousPreclinical
United States
Northeastern UniversityNortheastern University
20 Sep 2025
Leishmaniasis, CutaneousPreclinical
Spain
GSK PlcGSK Plc
20 Sep 2025
Trypanosomiasis, AfricanPreclinical
United States
Northeastern UniversityNortheastern University
20 Sep 2025
Trypanosomiasis, AfricanPreclinical
Spain
GSK PlcGSK Plc
20 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free